Search This Blog

Wednesday, August 14, 2019

Genmab reports Q2 results

Genmab (OTCPK:GNMSF): Q2 GAAP EPS of DKK1.35.
Revenue of DKK773.91M (+51.8% Y/Y)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.